ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics Aug 7, 2025 05:01PM
Vyome to go public and trade on the Nasdaq Capital Market under the ticker symbol “HIND” Jul 9, 2024 12:13PM
ReShape Lifesciences Inc. (RSLS) to Merge with Vyome Therapeutics, Enters Asset Purchase Agreement With Biorad Medisys Jul 9, 2024 08:31AM
ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys Jul 9, 2024 08:31AM